Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Have you confirmed
that all 2000 jobs are for their business? Or, are those jobs for clients of the staffing division of the company? There's a big diff. a commission to fill those jobs isn't that much.
Read
Quarterly Report
Note 2 - Management's Plan
On February 17, 2012, the Company sold substantially all of the assets of its Pharmacy segment to Medication Adherence Solutions, LLC ("MAS"), a subsidiary of The Walgreen Co. The cash proceeds of $2.0 million were paid by MAS directly to H.D. Smith Wholesale Drug Co. ("H.D. Smith") pursuant to the terms of the Secured Creditor Assignment and Release Agreement dated as of December 6, 2011 (the "Secured Creditor Agreement"). In addition, MAS assumed or paid at closing trade payables of the Pharmacy segment of approximately $1.5 million. The Company received no cash proceeds from this transaction. For a further description of the terms of the sale of the Pharmacy segment assets, see "Note 3
- Discontinued Operations".
As a result of this transaction, the Company no longer operates the Pharmacy segment as of February 17, 2012. The Pharmacy segment was previously reported as a discontinued operation.
The Company's sole remaining line of business is its Services segment, which consists of its Home Care and Medical Staffing business. The Company's Board of Directors continues to consider options with respect to the Services segment. The costs associated with being a public company are significant, and the Company is likely to have negative cash flow in the near term with no immediate access to additional equity or debt funding.
In addition, the Company has approximately $40.0 million in debt that matures April 1, 2012, which as of December 31, 2011 included approximately $9.5 million due to Comerica Bank under the line of credit agreement (the "Comerica Credit Line") that funds the operations of the Services segment (the "Comerica Debt") and approximately $30.5 million in unsecured promissory notes of Arcadia Resources, Inc. ("the ARI Debt"). The Company does not anticipate that it will be able to repay or refinance the ARI Debt at maturity and, therefore, the holders of the ARI Debt may declare the debt to be in default. For a further description of the outstanding debt of the Company, see "Note 7 - Long Term Obligations".
As a result of the above, the Company is continuing to pursue the sale of the Services business and is in on-going discussions with a number of parties regarding the potential sale.
While the Services segment is not in compliance with certain covenants under the Comerica Credit Line, the Comerica Debt has not been accelerated and Comerica continues to provide funding for the Services segment operations. The Company anticipates that Comerica will continue to provide funding to the Services segment until the business is sold. However, at any time Comerica has the right to accelerate the maturity of the Comerica Debt and declare the outstanding principal amount to be immediately due and payable. In addition, the indebtedness under the Comerica Credit Line matures and becomes due and payable on April 1, 2012. For a further description of the status of the Comerica Credit Line, see "Note 6 - Line of Credit".
If the Services segment is sold, the Company anticipates that the Comerica Debt will be assumed by the purchaser of the Services segment or repaid by the purchaser at closing. While the Company may realize sale proceeds in excess of the Comerica Debt from the sale of the Services segment, such proceeds are not expected to be sufficient to repay or refinance the ARI Debt. In such event, the Company would no longer have any operating businesses, would not be a going concern, and its liabilities would substantially exceed its tangible assets.
If the Services segment is not sold, the Company will need to renegotiate and extend the maturity of the Comerica Debt and the ARI Debt. There can be no assurances that the Company would be able to renegotiate and extend the maturity of this debt. Moreover, the Company would need to significantly improve its cash flow through increased revenue, additional cost reductions and operational improvements.
For these reasons, investors are strongly discouraged from trading in the Company's common stock because it is highly unlikely that there is any equity value related to the common shares.
Wishful thinking.
Short interest was only 27,000 on Jan 31. Short interest hasn't been over 80,000 for months. The volume over the past 3 weeks wasn't enough to support the shorting theory. This is a sell-off on record volume.
That's because most brokers
don't know how to do it. Making 10-20% a trade is suprisingly easy once you learn how.
Just picked up
a half million shares (.006), let's see what happens!
Buy Volume vs Sell Volume
Yikes!
Buy Volume 3,147,034
Sell Volume 14,071,132
Reverse Merger?
It looks like people are confusing a LOI about the agreement for the new CEO with a reverse merger. All I see is an RS.
Letter of Intent?
The LOI was for the agreement of George Ivakhnik becoming CEO. There's no RM coming, just an RS it looks like.
Yeah, unfortunately most people can't understand that
The daily MM shorting activity is a just a tool they use for efficient liquidity. It doesn't mean the stock is being shorted with malicious intent to the pps.
Do you even know what you're talking about?
And before you start, I've been on this board and have owned this stock since last fall. Check my post history before mouthing off.
With that said, explain to me what you think the Daily SHO report means? Most people can't, I have a feeling you're one of them.
Doesn't mean anything,
it's not what the short position is in the stock.
It was promoted
by pennystockguru.com, who receives no compensation. It would be a waste of time for pennystock newsletters. They mostly stick with stocks that are "in play". They're about active trading, not buy and hold. Pennystock newsletters are for traders, not investors.
HERE ARE THE FACTS OF THE WALGREENS B/O
They are keeping the services segment. They are only selling the pharmacy segement. Walgreens is paying $2 million for the pharmacy segment. The pharmacy segment owes $5 million but the creditors are accepting the $2 million as satisfaction for the entire debt.
That $2 million is it. That's all the money they are getting. They are not paying off the debt for the services segment. The services segment owes $30 million in April. The Walgreens buyout has nothing to do with that debt. A strong revenue stream from the services segment should, hopefully, allow them to refinance that $30 million. Then on to happier days.
New 52 week low (we're getting good at that).
Since September, I've lost count on all new 52 wk lows, it's all good. That word patience comes to mind.
If it doesn't bounce
off the .0025 we'll see a new 52 wk low.
WSHE looking for a bounce?
Chart starting to look a little appealing.
OS is 51 million?
On the 10-Q from Nov. 18 it states the OS is 30 million shares. So they almost doubled the OS in the past 6 weeks?
What happens to the shell?
Don't think so
YES, they can always change to a chapter 13, it's an absolute right that is not subject to waiver. No matter what the form says or doesn't say. Check the US Bankruptcy Code.
Buy Volume vs Sell Volume
Buy Volume 7,405,175
Sell Volume 7,302,972
Buy Volume vs Sell Volume
Buy Volume 5,315,175
Sell Volume 6,709,879
They don't have to pr
the news about ch. 7, they're not obligated to report it to shareholders.
Don't count on it
According to the SEC
"Stockholders do not have to be notified of the Chapter 7 case because they generally don't receive anything in return for their investment."
When was the last time they put a PR out?
Stop trading Q stocks all together?
Why?
The mistake is holding them. You should be saying, stop investing in Q stocks. Trading them is easy if you know what you are doing. You don't want to be in them the day they go to court. That's just asking for trouble. If the news is good you can chase it a little after the news. Any profit is good profit. People have to learn, don't look for the home run.
I think it's funny
That a few peoole show up after a record volume day and are here for no reason. It doesn't gain them any cretability, it does the exact opposite of such. No reason to post so many messages if their intent involves them not buying stock.
I think it's funny
That a few peoole show up after a record volume day and are here for no reason. It doesn't gain them any cretability, it does the exact opposite of such. No reason to post so many messages if their intent involves them not buying stock.
I would expect,
that any promotion would show up on hotstocks.com considering all of EMBA's previous pumps are on there. There's no doubt they're still diluting the piss out of it. But, it's not from a pennystock promotion. So, the question is, why the record volume? They have done 5 promotions so far this year. None of which came close to the volume that happened today.
It's NOT being promoted today.
No evidence of promotion thus far. If you have any post a link.
http://www.pumpsanddumps.com/2011/11/monday-november-14-2011-todays-pumps.html
http://newsletter.hotstocked.com/stocks/search/emba
If you play the pump, who cares?
Yeah it is, if I was more trusting,
I would average down more. A good PR and it should take off easily. It was down today on less than $2,000 worth of shares. I think somebody just wanted out of the thing. It looks like the big seller is done (I hope).
Talk about manipulation
Buy volume is 272,452 shares and Sell volume is only 45,000 shares. The bid/ask hasn't even moved.
I would,
but now I don't have enough $ for a plane ticket.
Losing 80% in 2 days isn't getting screwed?
Paying off those notes meant nothing. There's a big seller out there and stock is being diluted.
Great Job - Down 70% in 2 days.
Good job screwing the shareholders
Paid off debt early to avoid dilution? You're a class act Medisafe. lol Mgt. belongs in jail. lol
It's a bio-tech pharma stock
If you knew anything about the industry you would know that this is typical. This is par for the course for a drug company without an FDA approved drug on the market. A bio-tech stock can go 10-20 years without any revenue. There are other applications for the drug. Get a clue.
You're wrong
Memryte does work. They stopped the phase3 trial to do an efficacy review. That data showed that memryte, while being ineffective in men, does work on women. The plan is a phase3 trial on women only.
No such thing as a technical retrace
Exactly where do I say technicals are the reason why I think it will bounce? They're dumping, they want it to bounce so they can sell at a higher price. However, since you brought it up, how many examples of technicals working on pump and dumps would you like me to post?